Positions

Principal Investigator On

  • Private Grant  awarded by ORTHO-MCNEIL, INC. 2011 - 2015
  • Private Grant  awarded by Janssen 2013 - 2014

    • Investigator On

  • Private Grant  awarded by ALLERGAN, INC. 2019 - 2024
  • Private Grant  awarded by NAVITOR PHARMACEUTICALS INC. 2019 - 2024
  • Private Grant  awarded by INTRA-CELLULAR THERAPIES INC. 2018 - 2023
  • Private Grant  awarded by OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC 2018 - 2022
  • Private Grant  awarded by ALLERGAN SALES, LLC 2017 - 2022
  • Private Grant  awarded by ALLERGAN SALES, LLC 2017 - 2022
  • Private Grant  awarded by ALLERGAN SALES, LLC 2017 - 2022
  • Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC 2016 - 2022
  • Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC 2016 - 2021
  • Private Grant  awarded by Janssen 2016 - 2021
  • Private Grant  awarded by Janssen 2016 - 2021
  • Balanced Placebo Design with Varenicline: Pharmacological and Expectancy Effects on Medication Adherence  awarded by National Institute on Drug Abuse/NIH/DHHS 2018 - 2021
  • A Phase II/III Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of 2 Potential Disease Modifying Therapies in Individuals at Risk for and with Dominantly Inherited Alzheimer’s Disease  awarded by Washington University 2013 - 2020
  • Private Grant  awarded by NEURORX 2017 - 2020
  • Private Grant  awarded by NOVARTIS PHARMACEUTICALS CORPORATION - NEW 2019 - 2020
  • Private Grant  awarded by EISAI, INC. 2013 - 2020
  • Private Grant  awarded by ACADIA PHARMACEUTICALS, INC. 2017 - 2020
  • Private Grant  awarded by BIOGEN, INC. 2016 - 2020
  • Private Grant  awarded by ALLERGAN, INC. 2018 - 2020
  • Augmentation Versus Switch: Comparative Effectiveness Research Trial for Antidepressant Incomplete and Non-responders with Treatment Resistant Depression (ASCERTAIN-TRD)  awarded by PATIENT CENTERED OUTCOMES RESEARCH INSTITUTE 2017 - 2019
  • Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC 2017 - 2019
  • Private Grant  awarded by H. LUNDBECK A/S 2014 - 2019
  • Private Grant  awarded by GENOMIND 2016 - 2019
  • Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease(A4 Study)  awarded by University of Southern California 2016 - 2018
  • Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC 2015 - 2018
  • A Placebo-Controlled, Crossover Study of Fanapt® (iloperidone) Augmentation of SSRIs for Residual Anger and Irritability in Major Depressive Disorder  awarded by MASSACHUSETTS GENERAL HOSPITAL 2013 - 2018
  • Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC 2015 - 2018
  • Private Grant  awarded by H. LUNDBECK A/S 2014 - 2018
  • Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC 2015 - 2018
  • Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC 2017 - 2018
  • Private Grant  awarded by ALLERGAN, INC. 2016 - 2018
  • Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC 2015 - 2018
  • Private Grant  awarded by ALKERMES, INC. 2014 - 2017
  • Private Grant  awarded by FOREST LABORATORIES, INC. 2014 - 2017
  • Private Grant  awarded by NAUREX, INC. 2012 - 2017
  • Private Grant  awarded by NAUREX, INC. 2014 - 2017
  • Private Grant  awarded by ALKERMES, INC. 2014 - 2017
  • Private Grant  awarded by TAL MEDICAL 2013 - 2017
  • Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study: A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial  awarded by University of Southern California 2015 - 2016
  • Alzheimer's Disease Neuroimaging Initiative 2 (ADNI2)  awarded by University of Southern California 2015 - 2016
  • Alzehimer's Disease Neuroimaging Initiative (ADNI)  awarded by University of California, San Diego 2005 - 2016
  • Private Grant  awarded by OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC 2012 - 2016
  • Double-Blind, Placebo-Controlled, Proof-of-Concept (POC) Trial of CERC-501, a Kappa-Selective Opioid Receptor Antagonist, Augmentation of Antidepressant Therapy in Treatment-Resistant Depression (TRD)  awarded by MASSACHUSETTS GENERAL HOSPITAL 2015 - 2016
  • Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC 2014 - 2016
  • Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - The LEARN Study A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial  awarded by University of California, San Diego 2015
  • Private Grant  awarded by ASSUREX HEALTH INC. 2014 - 2015
  • Alzheimer's Disease Cooperative Study  awarded by University of California, San Diego 2013 - 2015
  • Private Grant  awarded by AVANIR PHARMACEUTICALS, INC. 2014 - 2015
  • Private Grant  awarded by TAKEDA GLOBAL RESEARCH & DEVELOPMENT CENTER 2012 - 2015
  • Private Grant  awarded by TAKEDA GLOBAL RESEARCH & DEVELOPMENT CENTER 2012 - 2015
  • Paliperidone and Lithium in the Treatment of Suicidality - Treatment Indication and Epigenetic Regulation  awarded by American Foundation for Suicide Prevention 2012 - 2014
  • Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC 2014
  • Private Grant  awarded by CERECOR, INC. 2013 - 2014
  • Private Grant  awarded by Elan 2012 - 2014
  • 2/2- Ziprasidone Augmentation of SSRIs for Treatment-Resistant Depression  awarded by National Institute of Mental Health/NIH/DHHS 2012 - 2014
  • 2/4-A Genomic Approach to Schizophrenia  awarded by National Institute of Mental Health/NIH/DHHS 2009 - 2014
  • Private Grant  awarded by INNOPHARMA, INC. 2013 - 2014
  • Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC 2012 - 2013
  • Private Grant  awarded by Pfizer Pharmaceuticals 2011 - 2013
  • Private Grant  awarded by Pfizer Pharmaceuticals 2011 - 2013
  • Comparative Effectiveness of a Second Generation Antipsychotic Mood Stabilizer and a Classic Mood Stabilizer for Bipolar Disorder  awarded by MASSACHUSETTS GENERAL HOSPITAL 2012 - 2013
  • Private Grant  awarded by JANSSEN AI (ALZHEIMER IMMUNOTHERAPY) R&D 2008 - 2013

    • Full Name

  • Roberta May